Weekly roundup


This week’s #PrescribingTips

Report all adverse reactions to veterinary medicines. When a drug is first licensed, it’s been tested in a few hundred animals at best. So rare adverse reactions won’t show up. We learn so much more through spontaneous reporting.

What else have we been up to this week?

  • We had a few days away visiting family, but still managed to keep working

  • Grapiprant verification done. Our editor is working on the final version.

  • Prepared the draft module on cannabidiol (CBD) for circulation to reviewers.

  • Started planning our visit to the London Vet Show #VetShow

  • Finished work on our free module about assessing new medicines.

  • Prepared a video on assessing new medicines for Canine Arthiritis Management to use as part of their workshops on multi-modal management of athritis.

  • Pleased to be collaborating with Vetstream. Reviewing Bovis drug monographs.

Our purpose...

...is to provide vets with high-quality, independent, comparative information they won't find elsewhere. However, it costs money to do this. We are a small, self-funded company of two dedicated full-timers (Andrea Tarr and Carl Russell), together with a team of regular and occasional writers, editors, reviewers, verifiers and proofreaders, who support our rigorous editorial process. We are absolutely passionate about independent information and empowering vets by giving them what they need to make rational decisions about medicines. Buying a subscription supports independent information you can trust. If you are getting free information ask yourself who is paying for it and why!